In 164 mechanically ventilated ICU patients needing light sedation, remimazolam besylate was non-inferior to propofol for successful sedation (97.5% in both groups; difference 0, 95% CI -6.5% to 6.4%, margin -8%).
RCTn = 164
Yang et al. Short-term light sedation with remimazolam besylate versus propofol in the ICU (SHOSREB): a multicentre, randomized, single-blind, controlled trial